IE37046L - IMIDAZO [5,1-f]-as-TRIAZINES - Google Patents

IMIDAZO [5,1-f]-as-TRIAZINES

Info

Publication number
IE37046L
IE37046L IE721433A IE143372A IE37046L IE 37046 L IE37046 L IE 37046L IE 721433 A IE721433 A IE 721433A IE 143372 A IE143372 A IE 143372A IE 37046 L IE37046 L IE 37046L
Authority
IE
Ireland
Prior art keywords
imidazo
aerosol
group
alkyl
additionally represent
Prior art date
Application number
IE721433A
Other versions
IE37046B1 (en
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of IE37046L publication Critical patent/IE37046L/en
Publication of IE37046B1 publication Critical patent/IE37046B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

1400999 Pharmaceutical aerosol composition ALLEN & HANBURYS Ltd 23 Oct 1972 [19 Nov 1971] 53750/71 Heading C4X [Also in Divisions A5 and C2] Compounds of the general Formula I and physiologically acceptable addition salts thereof, in which R 1 , R 2 , R 4 and R 5 each represents a hydrogen atom, or a C 1 -C 6 alkyl or C 2 -C 6 alkenyl group optionally substituted by one or more aryl groups, R 3 represents hydrogen or a C 1 -C 6 alkyl group, and R 1 may additionally represent a C 1 -C 6 acyl group and R 4 and R 5 may additionally represent a cycloalkyl or aryl group are used in pharmaceutical compositions which may be prepared in the form of an aerosol spray. An example describes the preparation of an inhalation aerosol from 2- amino - 5 - methyl - 7 - propyl - imidazo[5,1- f]-cis-triazine-4(3H)-one, sorbitan trioleate, trichlorofluoromethane and dichlorodifluoromethane (Ex. 12). [GB1400999A]
IE1433/72A 1971-11-19 1972-10-23 Imidazo-triazine compounds and their use in therapeutic compositions IE37046B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5375071A GB1400999A (en) 1971-11-19 1971-11-19 Imidazo-triazine compounds and their use in therapeutic compositions

Publications (2)

Publication Number Publication Date
IE37046L true IE37046L (en) 1973-05-19
IE37046B1 IE37046B1 (en) 1977-04-27

Family

ID=10468856

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1433/72A IE37046B1 (en) 1971-11-19 1972-10-23 Imidazo-triazine compounds and their use in therapeutic compositions

Country Status (18)

Country Link
US (1) US3840537A (en)
JP (1) JPS563873B2 (en)
AT (1) AT321923B (en)
AU (1) AU472127B2 (en)
BE (1) BE791025A (en)
CA (1) CA990292A (en)
CH (1) CH594671A5 (en)
DE (1) DE2255172A1 (en)
DK (1) DK138691B (en)
ES (1) ES408736A1 (en)
FR (1) FR2160407B1 (en)
GB (1) GB1400999A (en)
IE (1) IE37046B1 (en)
IL (1) IL40686A (en)
NL (1) NL7215646A (en)
PH (1) PH9669A (en)
SE (1) SE402915B (en)
ZA (1) ZA727532B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1457873A (en) * 1973-01-04 1976-12-08 Allen & Hanburys Ltd Imidazotriazines
DE2314488C3 (en) * 1973-03-23 1979-01-04 C.H. Boehringer Sohn, 6507 Ingelheim 8- (2,6-Dichlorophenyl) -7- (4-chlorophenyl) -5-oxo-233,8-tetrahydro-imidazo [1,2-a] -s-triazine, process for its preparation and medicament containing it
DE2335193A1 (en) * 1973-07-11 1975-01-30 Hoechst Ag BIS-TRIAZINOBENZIMIDAZOLE AND THEIR PRODUCTION
US4107307A (en) * 1977-02-03 1978-08-15 American Cyanamid Company Imidazo [1,5-d]-as-triazine-4(3H)-ones and thiones
US4115572A (en) * 1977-02-03 1978-09-19 American Cyanamid Company Imidazo-[1,5-d]-as-triazin-1(2H)-ones and method of ameliorating asthma
USRE30511E (en) * 1977-02-03 1981-02-10 American Cyanamid Company Imidazo[1,5-d]-as-triazine-4(3H)-ones and thiones
DK109578A (en) * 1977-03-25 1978-09-26 Allen & Hanburys Ltd PROCEDURE FOR MAKING HETEROCYCLIC COMPOUNDS
US4107308A (en) * 1977-10-18 1978-08-15 American Cyanamid Company Imidazo[1,5-d]-as-triazines
US4308384A (en) * 1978-09-18 1981-12-29 Glaxo Group Limited Production of triazinones
HU187474B (en) * 1981-11-18 1986-01-28 Gyogyszerkutato Intezet,Hu Process for producing new spiro-pyrazole-square bracket-1,5-d-square bracket closed-square bracket-1,2,4-square bracket closed-triazine derivatives
US4395547A (en) * 1982-02-10 1983-07-26 American Cyanamid Co. Process for preparing 1-substituted-6-n-propyl-8-methylimidazo[1,5-d]-as-triazin-4(3H)-ones
AU622330B2 (en) * 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
ATE213246T1 (en) * 1997-11-12 2002-02-15 2-PHENYL-SUBSTITUTED IMIDAZOTRIAZINONES AS PHOSPHODIESTERASE INHIBITORS
DE19827640A1 (en) * 1998-06-20 1999-12-23 Bayer Ag New imidazotriazine derivatives useful as smooth muscle relaxants for treating e.g. cardiovascular disorders, cerebrovascular disorders, or erectile dysfunction
IL141335A0 (en) 1998-08-26 2002-03-10 Smithkline Beecham Corp Therapies for treating pulmonary diseases
EA006685B1 (en) 1999-08-21 2006-02-24 Алтана Фарма Аг Synergistic combination
DK1392314T3 (en) * 2001-05-09 2007-03-12 Bayer Healthcare Ag Hitherto unknown use of 2- [2-ethoxy-5- (4-methyl-piperazine-1-sulfonyl) -phenyl] -5-methyl-7-propyl-3H-imidazo [5,1-f] [1,2 , 4] triazin-4-one
GB0113343D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel Heterocycles 2
GB0113344D0 (en) * 2001-06-01 2001-07-25 Bayer Ag Novel heterocycles 3
DE10135815A1 (en) 2001-07-23 2003-02-06 Bayer Ag Use of imidazo-triazinone derivative phosphodiesterase 5 inhibitors e.g. for treatment of cardiac insufficiency, psoriasis, diabetes, cancer, glaucoma, bladder disease, Parkinson's disease or pain
DE10232113A1 (en) * 2002-07-16 2004-01-29 Bayer Ag Medicinal products containing vardenafil hydrochloride trihydrate
ES2326808T3 (en) * 2003-04-01 2009-10-20 Smithkline Beecham Corporation IMIDAZOTRIAZINE COMPOUNDS FOR THE TREATMENT OF CANCER DISEASES.
EP2168968B1 (en) 2004-04-02 2017-08-23 OSI Pharmaceuticals, LLC 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
DE102005001989A1 (en) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenous formulations of PDE inhibitors
DE102005009240A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with improved pharmacokinetic properties
DE102005009241A1 (en) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Dosage forms with controlled bioavailability
BRPI0616633A2 (en) * 2005-09-29 2011-06-28 Bayer Healthcare Ag pde inhibitors and combinations thereof for the treatment of urological disorders
EP1951724B1 (en) * 2005-11-17 2011-04-27 OSI Pharmaceuticals, Inc. FUSED BICYCLIC mTOR INHIBITORS
KR20100029762A (en) * 2007-06-13 2010-03-17 바이엘 쉐링 파마 악티엔게젤샤프트 Pde inhibitors for the treatment of hearing impairment
CN102405214A (en) 2009-04-20 2012-04-04 Osi药物有限责任公司 Preparation of c-pyrazine-methylamines
CN103374002B (en) * 2012-04-19 2015-07-15 山东轩竹医药科技有限公司 Phosphodiesterase-5 inhibitor
US20180044343A1 (en) * 2015-03-16 2018-02-15 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic imidazolo derivative
WO2017000276A1 (en) * 2015-07-01 2017-01-05 Merck Sharp & Dohme Corp. Bicyclic heterocyclic compounds as pde2 inhibitors
WO2017204316A1 (en) * 2016-05-27 2017-11-30 塩野義製薬株式会社 5-oxo-1,2,4-triazine derivative, and pharmaceutical composition thereof

Also Published As

Publication number Publication date
FR2160407B1 (en) 1975-10-17
DK138691C (en) 1979-03-26
AU472127B2 (en) 1976-05-20
US3840537A (en) 1974-10-08
DK138691B (en) 1978-10-16
AU4819172A (en) 1974-05-16
ZA727532B (en) 1973-07-25
CH594671A5 (en) 1978-01-13
GB1400999A (en) 1975-07-16
ES408736A1 (en) 1976-03-01
AT321923B (en) 1975-04-25
IL40686A0 (en) 1972-12-29
DE2255172A1 (en) 1973-05-24
IL40686A (en) 1975-12-31
PH9669A (en) 1976-02-10
SE402915B (en) 1978-07-24
JPS563873B2 (en) 1981-01-27
BE791025A (en) 1973-05-07
CA990292A (en) 1976-06-01
NL7215646A (en) 1973-05-22
JPS4857993A (en) 1973-08-14
IE37046B1 (en) 1977-04-27
FR2160407A1 (en) 1973-06-29

Similar Documents

Publication Publication Date Title
IE37046L (en) IMIDAZO [5,1-f]-as-TRIAZINES
ES2044836T3 (en) DERIVED FROM PIPERIDINE, ITS USE AND PHARMACEUTICAL COMPOUND CONTAINING IT.
IE37925B1 (en) 17 beta-haloalkoxycarbonyl-17 alpha-oxy steroids
ES483767A1 (en) Alpha-(N-arylsulfonyl-L-argininamides, processes for their preparation and pharmaceutical compositions containing these substances.
CA2155673A1 (en) N-alkyl-2-substituted atp analogues
ZA844585B (en) 2-pyrimidinyl-1-piperazine derivatives,processes for their preparation and medicaments containing them
HU170778B (en) Fungicide compositions, and process for producing l-propyl-imidazole derivatives and salts thereof as active agents
ATE4593T1 (en) PYRAZOLINE DERIVATIVES, PROCESSES FOR THE PREPARATION OF THESE COMPOUNDS, AND INSECTICIDE COMPOSITION BASED ON THESE COMPOUNDS.
ATE144983T1 (en) NEW TRICYCLIC COMPOUND OR SALTS THEREOF, METHOD OF PREPARATION AND ANTIMICROBIAL ACTIVE INGREDIENTS CONTAINING SAME
GB1507957A (en) Nitrofuryl-pyrazole derivatives methods for producing them and medicaments comprising them
GB1435573A (en) Indoloquinolizines
IE41440L (en) Thiatetracyclines
ATE35812T1 (en) GAMMA BUTYROLACTONE DERIVATIVES, PROCESSES FOR MANUFACTURE THE SAME AND IMMUNOMODULATING PREPARATIONS CONTAINING THE SAME ACTIVE INGREDIENTS.
IE34812L (en) Evomonoside derivatives.
DE3565104D1 (en) Thiadiazine compound, process for its preparation and pharmaceutical compositions containing it
DK152053C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF ANTHRACYCLING LYCOSIDES OR THEIR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS
SE8803931L (en) NEW ALCOXIDE DERIVATIVES OF GINKGOLIDES, THEIR PREPARATION AND THERAPEUTIC CONTENTS
IE893258L (en) New 2-carbonyl substituted n,n'-di-(trimethoxybenzoyl)¹piperazines, process for preparing the same and¹therapeutical compounds containing them
FI853866A0 (en) 2-PYRIDIN-THIOL DERIVATIVES, FOERFARANDE FOER FRAMSTAELLNING AV DESSA SAMT PHARMACEUTICAL FOERENINGAR INNEHAOLLANDE DESSA.
JPS5259186A (en) Preparation of 3-cephem compounds by reduction
ES485157A1 (en) Benzimidazolyl-2-carbamic acid esters, medicaments based thereon and process for their preparation.
ES474052A1 (en) 1-N-substituted 1.4-dihydropyridazine derivatives, method for their preparation and their use for pharmaceuticals.
IL49208A (en) 13,14-dehydro-16-fluoro prostanoic acid derivatives of the f2,a2 and e2 series,process for their preparation and pharmaceutical compositions containing same
SE7614537L (en) PROCEDURE FOR MAKING N? 721- (2-TETRA - HYDROFURYL) -5-FLUORURACIL
IE39049L (en) 1, 4-dihydroquinolines.